|
|
.
See Category: Factors influencing health status and contact with health services
ICD-10 (CM) Code and Descriptor
|
Z41.8 |
Encounter for other procedures for purposes other than remedying health state
|
Z418 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 16.25%
|
25.72%
|
21.64%
|
13.42%
|
7.53%
|
4.80%
|
3.00%
|
1.77%
|
1.29%
|
0.98%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for Z41.8*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
96372
|
THER/PROPH/DIAG INJ SC/IM |
3,227
|
3,321
|
|
Q5111
|
INJECTION, UDENYCA 0.5 MG |
1,460
|
17,465
|
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
895
|
895
|
|
J2505
|
INJECTION, PEGFILGRASTIM 6MG |
884
|
884
|
|
80053
|
COMPREHEN METABOLIC PANEL |
880
|
882
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
795
|
799
|
|
96365
|
THER/PROPH/DIAG IV INF INIT |
674
|
675
|
|
J1459
|
INJ IVIG PRIVIGEN 500 MG |
492
|
19,170
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
392
|
392
|
|
96366
|
THER/PROPH/DIAG IV INF ADDON |
353
|
554
|
|
83735
|
ASSAY OF MAGNESIUM |
345
|
346
|
|
80061
|
LIPID PANEL |
268
|
268
|
|
84443
|
ASSAY THYROID STIM HORMONE |
257
|
257
|
|
85027
|
COMPLETE CBC AUTOMATED |
249
|
249
|
|
81001
|
URINALYSIS AUTO W/SCOPE |
245
|
245
|
|
J0485
|
BELATACEPT INJECTION |
245
|
69,500
|
|
80197
|
ASSAY OF TACROLIMUS |
210
|
211
|
|
83721
|
ASSAY OF BLOOD LIPOPROTEIN |
195
|
195
|
|
Q5106
|
INJ RETACRIT NON-ESRD USE |
176
|
5,300
|
|
80048
|
METABOLIC PANEL TOTAL CA |
166
|
166
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
Z41.8 related to the following DRG Codes:
951
|
